Clinical Development

(Image: Getty/gopixa)

European CRO Optimapharm enters US market

By Melissa Fassbender

The Croatia-headquartered contract research organization (CRO) has opened its first office in the US and plans to further expand its footprint organically and through potential acquisitions.